News und Analysen
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 46th Annual
Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with
Lonza Publishes 2024 Comparative Financials Under One Lonza Organizational Structure
Pfizer Enters into Exclusive Licensing Agreement with 3SBio
Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the
Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer
Lonza Announces Results of the 2025 Annual General Meeting – All Motions Proposed by Board of Directors Approved
Lonza Q1 2025 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for Full-Year 2025
Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance
Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1).
EXECUTIVE COMMENTARY
Dr. Albert Bourla, Chairman and CEO of
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care
Pfizer Declares Second-Quarter 2025 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company’s common stock, payable June 13, 2025, to holders of the Common
Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting
Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place May
Fortune 500 Leaders Share AI-powered Supply Chain Excellence on Stage at OMP Conference
Industry giants, including AstraZeneca, Johnson & Johnson, General Mills, and Kraft Heinz, to present real-world case studies in Miami
MIAMI, FL / ACCESS Newswire / October 22, 2025 / OMP,
Führende Fortune-500-Unternehmen berichten im Rahmen einer OMP-Konferenz über KI-Kompetenzen zur Stärkung der Lieferkette
Branchenriesen wie AstraZeneca, Johnson & Johnson, General Mills und Kraft Heinz präsentieren in Miami Fallstudien aus der Praxis
MIAMI, FL / ACCESS Newswire / 22. Oktober 2025 / OMP, ein
Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models
- Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions.
- High-quality biological patient data, enriched and
Owkin bringt K Pro auf den Markt: Der erste agentenbasierte KI-Co-Pilot für Biopharma mit biologischen Argumentationsmodellen
- Unternehmensplattform, die über natürliche Sprache abgefragt wird, um Pharmaunternehmen, Biotech-Unternehmen und Investoren dabei zu helfen, optimierte Entscheidungen zu treffen.
-
GSK stellt auf dem Gartner Supply Chain Planning Summit seine beschleunigte IBP-Transformation mit OMP vor
ANTWERPEN, BE / ACCESS Newswire / 9. Oktober 2025 / OMP, ein führender Anbieter von Lösungen für die Lieferkettenplanung, stellt auf dem Gartner Supply Chain Planning Summit 2025 in London
GSK Unveils Fast-Tracked IBP Transformation with OMP at Gartner Supply Chain Planning Summit
ANTWERPEN, BE / ACCESS Newswire / October 9, 2025 / OMP, a leader in supply chain planning solutions, is spotlighting at the Gartner Supply Chain Planning Summit 2025 in London how GSK is
Belgische Aircrew schließt MQ-9B-Training ab
Das Training für den MQ-9B SkyGuardian® von GA-ASI wurde an mehreren Standorten durchgeführt, darunter das Flight Test & Training Center und Desert Horizon
San Diego, Kalifornien / Access
Belgian Aircrew Completes MQ-9B Training
GA-ASI's MQ-9B SkyGuardian® Training Was Conducted at Multiple Sites, Including Flight Test & Training Center and Desert Horizon
SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 17, 2025 /
Horizon Petroleum Provides European Gas Market Summary and a Concession Update on Its Gas Assets in Poland
May 08, 2025, CALGARY, ALBERTA – Horizon Petroleum Ltd. (TSXV: HPL, FRA: HPM, Tradegate: HPM) ("Horizon" or the "Company") is pleased to provide a corporate update on its progress on
Horizon Petroleum gibt Überblick über den europäischen Gasmarkt und ein Konzessionsupdate zu seinen Gas-Assets in Polen
8. Mai 2025 - CALGARY, ALBERTA / IRW-Press / Horizon Petroleum Ltd. (TSXV: HPL, FWB: HPM, Tradegate: HPM) („Horizon“ oder das „Unternehmen“) freut sich, ein Unternehmensupdate zum Fortschritt
P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning at Gartner Supply Chain Symposium/Xpo 2026
How decision velocity is closing the gap between insight and action across one of the world's most complex value chains
ATLANTA, GA / ACCESS Newswire / April 14, 2026 / OMP, a leader in
P&G und OMP präsentieren auf dem Gartner Supply Chain Symposium/Xpo 2026 den Weg zu einer autonomen, entscheidungsorientierten Planung
Wie Entscheidungsgeschwindigkeit die Lücke zwischen Erkenntnis und Umsetzung in einer der komplexesten Wertschöpfungsketten der Welt schließt
ATLANTA, GA / ACCESS Newswire / 14. April 2026
NurExone & Bayer: Ehemaliger Bayer-Forscher sieht enormes Potenzial in der Exosomen-Technologie – „Regeneration statt nur Verlangsamung von Krankheiten“
Ein ehemaliger leitender Wissenschaftler von Bayer, der an der Entwicklung des bis zur FDA-Zulassung gebrachten Medikaments Finerenon beteiligt war, teilt seine Experteneinschätzung zur
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for their outstanding contribution at the recent OMP Conference. The